Location · Gainesville, FL
Clinical trials in Gainesville, FL
181 recruiting studies have a site in Gainesville, and 69 of them accept healthy volunteers.
181 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease
Hoffmann-La Roche
- Location
- Gainesville, FL + 5 other US sites
- Eligibility basics
- Ages 1 mo+
- RecruitingPhase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Eli Lilly and Company
- Location
- Gainesville, FL + 136 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
Ascidian Therapeutics, Inc
- Location
- Gainesville, FL + 8 other US sites
- Eligibility basics
- Ages 12+
- Recruiting
Zenith® Fenestrated+ Clinical Study
Cook Research Incorporated
- Location
- Gainesville, FL + 29 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
AstraZeneca
- Location
- Gainesville, FL + 30 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
Hoffmann-La Roche
- Location
- Gainesville, FL + 9 other US sites
- Eligibility basics
- Ages 4 mo–2
- RecruitingPhase 2
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Neuron23 Inc.
- Location
- Gainesville, FL + 43 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 2/Phase 3
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
EyeBiotech Ltd.
- Location
- Gainesville, FL + 66 other US sites
- Eligibility basics
- Ages 50+
- Recruiting
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Shockwave Medical, Inc.
- Location
- Gainesville, FL + 66 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Amgen
- Location
- Gainesville, FL + 57 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingPhase 2/Phase 3
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Janssen Research & Development, LLC
- Location
- Gainesville, FL + 44 other US sites
- Eligibility basics
- Ages 60+
- RecruitingPhase 2
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
ACADIA Pharmaceuticals Inc.
- Location
- Gainesville, FL + 27 other US sites
- Eligibility basics
- Ages 55–84
- RecruitingPhase 3
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Intra-Cellular Therapies, Inc.
- Location
- Gainesville, FL + 46 other US sites
- Eligibility basics
- Ages 5–17
- RecruitingPhase 2
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
AbbVie
- Location
- Gainesville, FL + 53 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
DePuy Orthopaedics
- Location
- Gainesville, FL + 1 other US site
- Eligibility basics
- Ages 21+
- RecruitingPhase 3
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
Intra-Cellular Therapies, Inc.
- Location
- Gainesville, FL + 27 other US sites
- Eligibility basics
- Ages 5–17
- RecruitingPhase 3
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Adverum Biotechnologies, Inc.
- Location
- Gainesville, FL + 78 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc.
- Location
- Gainesville, FL + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1
Sanofi
- Location
- Gainesville, FL + 4 other US sites
- Eligibility basics
- Ages 10–55
- RecruitingPhase 2
Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
Hillhurst Biopharmaceuticals, Inc.
- Location
- Gainesville, FL + 4 other US sites
- Eligibility basics
- Ages 40–80
- Recruiting
HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
ReGelTec, Inc.
- Location
- Gainesville, FL + 13 other US sites
- Eligibility basics
- Ages 22–85
- RecruitingPhase 3
Study of ALK-001 on the Progression of Stargardt Disease
Alkeus Pharmaceuticals, Inc.
- Location
- Gainesville, FL + 11 other US sites
- Eligibility basics
- Ages 8–45
- Recruiting
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
JenaValve Technology, Inc.
- Location
- Gainesville, FL + 33 other US sites
- Eligibility basics
- Any age listed
- Recruiting
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Medtronic Cardiovascular
- Location
- Gainesville, FL + 68 other US sites
- Eligibility basics
- Ages 18+